The Cohort Study for Asthma in China
The Cohort Study for Asthma in China: an Prospective Observational Study
Beijing Chao Yang Hospital
400 participants
Jan 1, 2023
OBSERVATIONAL
Conditions
Summary
The study is to establish a standardized asthma cohort study, build an information network platform system and a biospecimen bank for asthma cohort, establish clear follow-up standards and norms, observe the asthma outcomes and identify biomarkers to predict asthma outcomes.
Eligibility
Inclusion Criteria3
- Age \>18
- Meet the 2023 edition of GINA asthma diagnostic criteria
- Subjects must sign informed consent prior to study participation, participate in the study according to the protocol and follow up for 2 years
Exclusion Criteria10
- Suffering from other massive lung tissue destructive diseases such as severe bronchiectasis and tuberculosis
- Severe pleural disease and/or sternal and rib lesions
- Serious uncontrolled disease of other system
- Thoracic or abdominal surgery in the past 3 months
- Eye surgery in the past three months
- Retina detachment
- Myocardial infarction within the last 3 months
- Hospitalized for heart disease within the past 3 months
- Ongoing anti-tuberculosis treatment
- Pregnancy or breast feeding
Interventions
lung function test, chest CT, induced sputum, blood routine test, IgE test, FeNO test, six minutes walk test, questionnaires for asthma were performed. All interventions was made according to routine diagnosis and treatment.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05937334